Chem. J. Chinese Universities ›› 2014, Vol. 35 ›› Issue (7): 1509.doi: 10.7503/cjcu20140122

• Physical Chemistry • Previous Articles     Next Articles

Fabrication and TXL Anti-cancer Drug Delivery of Magnetic Mesoporous Silica Nanoparticles

ZHANG Zhuoqi1, GENG Haoran2, XUAN Ruifei2, CHEN Minmin2, CHEN Hui2, LIU Aihui3,*(), CAO Xichuan2   

  1. 1. The Affiliated Hospital of Xuzhou Medical College, Xuzhou 221002, China
    2. School of Materials Science and Engineering, China University of Mining and Technology, Xuzhou 221116, China
    3. Jiangsu Provice Key Laboratory for Interventional Medical Device, Huaiyin Institute of Technology, Huaiyin 223003, China
  • Received:2014-03-12 Online:2014-07-10 Published:2014-05-19
  • Contact: LIU Aihui E-mail:abc623044118@163.com

Abstract:

Magnetic Fe3O4@SiO2 mesoporous silica nanoparticles(MSNs) were synthesized with Fe3O4 nanoparticles as crystal core, cetyltrimethylammium bromide(CTAB) as structural directional agent through the hydrolysis of tetraethoxysilane(TEOS) and self-assembly procedure under the basic conditions. The synthesized MSNs were characterized via the XRD, FTIR, TEM and N2 adsorptiom-desorption. The results show that these MSNs have high sepcific surface area of 932 cm2/g, particles size of 150 nm and typical hexagonal packing mesoporous structure. Simultaneously, all Fe3O4 nanoparticles are perfectly embedded in silica bulk. As a TXL carrier, Fe3O4@SiO2 exhibits good adsorption with the maximum adsorption capacity of 80 mg/g and TXL-Fe3O4@SiO2 has a more than 120 h sustained release for TXL with accumulative quantity of 30 mg/g. While the release behaviour is controlled by various pH values. Higher the pH is, larger the accumulative release is. Experiments of cytotoxicity on HeLa cells indicate that the Fe3O4@SiO2 particles exhibit excellent biocompatibility. TXL-Fe3O4@SiO2 shows significant inhibition effect on HeLa cells than bare TXL under the same drug concentration.

Key words: Magnetic mesoporous nanoparticles, Paelitaxel(TXL), Anticancer drug delivery, HeLa cell, Fe3O4 nanoparticles

TrendMD: